KPNA2 promotes the progression of gastric cancer by regulating the alternative splicing of related genes

• Published in: Scientific reports Vol. 14; no. 1; pp. 17140 - 21
• Main Authors: Chen, Xia, Wei, Hui, Yue, Ailin, Zhang, Huiyun, Zheng, Ya, Sun, Weiming, Zhou, Yongning, Wang, Yuping
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 25.07.2024; Nature Publishing Group; Nature Portfolio
• Subjects: 631/67/1504/1829; 692/4020; alpha Karyopherins - genetics; alpha Karyopherins - metabolism; Alternative Splicing; Cell growth; Cell Line, Tumor; Cell migration; Cell Movement - genetics; Cell proliferation; Cell Proliferation - genetics; Disease Progression; Exon skipping; Female; Gastric cancer; Gene Expression Regulation, Neoplastic; Gene regulation; Humanities and Social Sciences; Humans; Immune response; Immunization; Immunoprecipitation; KPNA2; Lymph nodes; Lymphatic Metastasis; Male; Metastases; Middle Aged; multidisciplinary; Ribonucleic acid; RNA; RNA-binding protein; Science; Science (multidisciplinary); Splicing factors; Splicing regulatory sequence; Stomach Neoplasms - genetics; Stomach Neoplasms - metabolism; Stomach Neoplasms - pathology; Wound healing; Alternative splicing; Immunization; KPNA2; Gastric cancer; Splicing regulatory sequence
• DOI: 10.1038/s41598-024-66678-7
• ISSN: 2045-2322

RNA-binding proteins (RBPs) play critical roles in genome regulation. In this study, we explored the latent function of KPNA2, which is an essential member of the RBP family, in the regulation of alternative splicing (AS) in gastric cancer (GC). We analyzed the role of KPNA2 in regulating differential expression and AS via RNA sequencing (RNA-seq) and improved RNA immunoprecipitation sequencing (iRIP-seq). Clinical specimens were used to analyze the associations between KPNA2 expression and clinicopathological characteristics. CCK8 assays, transwell assays and wound healing assays were performed to explore the effect of KPNA2/WDR62 on GC cell progression. KPNA2 was shown to be highly expressed in GC cells and tissues and associated with lymph node metastases. KPNA2 promoted the proliferation, migration and invasion of GC cells and primarily regulated exon skipping, alternative 3's splice sites (A3SSs), alternative 5' splice sites (A5SSs), and cassette exons. We further revealed that KPNA2 participated in biological processes related to cell proliferation, and the immune response in GC via the regulation of transcription. In addition, KPNA2 preferentially bound to intron regions. Notably, KPNA2 regulated the A3SS AS mode of WDR62, and upregulation of WDR62 reversed the KPNA2 downregulation-induced inhibition of GC cell proliferation, migration and invasion. Finally, we discovered that the AS of immune-related molecules could be regulated by KPNA2. Overall, our results demonstrated for the first time that KPNA2 functions as an oncogenic splicing factor in GC that regulated the AS and differential expression of GC-related genes, and KPNA2 may be a potential target for GC treatment.